Related Experiment Videos

Structure and pharmacology of vertebrate GABAA receptor subtypes

P J Whiting¹, R M McKernan, K A Wafford

¹Neuroscience Research Centre, Merck Sharp & Dohme, Harlow, England.

International Review of Neurobiology

|January 1, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration.

Alzheimer's research & therapy·2020

Comparative Effects of LY3020371, a Potent and Selective Metabotropic Glutamate (mGlu) 2/3 Receptor Antagonist, and Ketamine, a Noncompetitive N-Methyl-d-Aspartate Receptor Antagonist in Rodents: Evidence Supporting the Use of mGlu2/3 Antagonists, for the Treatment of Depression.

The Journal of pharmacology and experimental therapeutics·2017

The role of K₂p channels in anaesthesia and sleep.

Pflugers Archiv : European journal of physiology·2014

Development and pharmacological characterization of a model of sleep disruption-induced hypersensitivity in the rat.

European journal of pain (London, England)·2014

A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.

British journal of pharmacology·2012

Differential effects of NMDA antagonists on high frequency and gamma EEG oscillations in a neurodevelopmental model of schizophrenia.

Neuropharmacology·2011

See all related articles